[
    "{\"step_by_step_thinking\": \"1. Perioperative bridging refers to the use of anticoagulation therapy to bridge the gap between stopping a patient's regular anticoagulant medication and the time of surgery. 2. Fondaparinux is a type of anticoagulant medication that works by inhibiting factor Xa. 3. The decision to use perioperative bridging with fondaparinux depends on several factors, including the patient's individual risk of thromboembolism and bleeding. 4. Fondaparinux has been shown to be effective in preventing thromboembolic events in patients with atrial fibrillation who are undergoing surgery. 5. However, fondaparinux is associated with an increased risk of bleeding, which may outweigh the benefits in some patients. 6. Therefore, the role of fondaparinux in perioperative bridging is not clear-cut and depends on the individual patient's risk-benefit profile.\", \"answer_choice\": \"C. maybe\"}"
]